Translate
Downloads
Description:
Important
It is mandatory that all vaccination providers report all administered influenza vaccinations to the Australian Immunisation Register.
Funded influenza immunisation schedule
Influenza vaccine is funded and recommended under the National Immunisation Program (NIP) for the following groups^:
- All children aged 6 months to less than 5 year of age
- All Aboriginal and Torres Strait Islander people aged 6 months and older
- Pregnant women (during any stage of pregnancy)
- People with eligible medical conditions (see below)
- All people aged 65 years and older.
^please note that providers may charge a service fee
2024 influenza vaccines
| Children aged 6 months to less than 5 years* |
|---|
| Fluarix Tetra 0.5mL (GSK) |
| Vaxigrip Tetra 0.5mL (Sanofi) |
| People aged 5 years to less than 65 years* |
|---|
| Fluarix Tetra 0.5mL (GSK) |
| Vaxigrip Tetra 0.5mL (Sanofi) |
| Flucelvax 0.5mL (Seqirus) |
| People aged 65 years and older* |
|---|
| Fluad Quad 0.5mL (Seqirus) |
2024 vaccine information
- Influenza vaccines are not recommended for infants less than 6 months of age.
- Children aged 6 months to less than 9 years receiving the influenza vaccine for the first time require two doses at least 4 weeks apart.
- People aged 65 years and older are preferentially recommended to receive an adjuvanted vaccine such as Fluad Quad (funded) or Fluzone High Dose Quadrivalent (private) for best protection.
- Influenza vaccines can be co-administered (given on the same day) with other vaccines*
*There is limited safety data for the co-administration of Fluad Quad and Shingrix. While it is preferred to separate administration by a few days, it is acceptable to co-administer these vaccines to avoid missing opportunities to vaccinate eligible people.
Document accessibility
We aim to provide documents in an accessible format. If you are having problems using a document with your accessibility tools, please contact us for help.
Publication date:
Publication type:
Fact sheets